Abstract:A variety of adverse environmental factors during pregnancy cause maternal chronic stress. Caffeine is a common stressor, and its consumption during pregnancy is widespread. Our previous study showed that prenatal caffeine exposure (PCE) increased maternal blood glucocorticoid levels and caused abnormal development of offspring. However, the placental mechanism for fetal development inhibition caused by PCE-induced high maternal glucocorticoid has not been reported. This study investigated the effects of PCE-induced high maternal glucocorticoid level on placental and fetal development by regulating placental 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2) expression and its underlying mechanism. First, human placenta and umbilical cord blood samples were collected from women without prenatal use of synthetic glucocorticoids. We found that placental 11β-HSD2 expression was significantly correlated with umbilical cord blood cortisol level and birth weight in male newborns but not in females. Furthermore, we established a rat model of high maternal glucocorticoids induced by PCE (caffeine, 60 mg/kg·d, ig), and found that the expression of 11β-HSD2 in male PCE placenta was decreased and negatively correlated with the maternal/fetal/placental corticosterone levels. Meanwhile, we found abnormal placental structure and nutrient transporter expression. In vitro, BeWo cells were used and confirm that 11β-HSD2 mediated inhibition of placental nutrient transporter expression induced by high levels of glucocorticoid. Finally, combined with the animal and cell experiments, we further confirmed that high maternal glucocorticoid could activate the GR-C/EBPα-Egr1 signaling pathway, leading to decreased expression of 11β-HSD2 in males. However, there was no significant inhibition of placental 11β-HSD2 expression, placental and fetal development in females. In summary, we confirmed that high maternal glucocorticoids could regulate placental 11β-HSD2 expression in a sex-specific manner, leading to differences in placental and fetal development. This study provides the theoretical and experimental basis for analyzing the inhibition of fetoplacental development and its sex difference caused by maternal stress.

A Functional Fetal HSD11B2[CA]n Microsatellite Polymorphism is Associated with Maternal Serum Cortisol Concentrations in Pregnant Women

[Association Between HSD11B2 Gene Polymorphism and Fetal Growth].

Placental 11Β-Hsd2 and Cardiometabolic Health Indicators in Infancy

Polymorphism in Maternal HLA-DRB5 is Associated with the Risk of Preeclampsia in Chinese Population

Relationship Between ABCB1 Polymorphism and the Cortisol Transportation in Maternofetal Interface

Alteration in Methylation Level at 11Β-Hydroxysteroid Dehydrogenase Type 2 Gene Promoter in Infants Born to Preeclamptic Women

Relationship Between 11Β-Hydroxysteroid Dehydrogenase 2 Gene Expression in Placenta of Pregnancy Induced Hypertension Mother and Newborn′s Birth Weight

Compartmentalized localization of 11β-HSD 1 and 2 at the feto-maternal interface in the first trimester of human pregnancy

Differential expression of placental tissue 11β-HSD1 and 11β-HSD2 in patients with gestational diabetes mellitus

Rhythm of Fetoplacental 11β-Hydroxysteroid Dehydrogenase Type 2 - Fetal Protection From Morning Maternal Glucocorticoids

11-Β Hydroxysteroid Dehydrogenase Gene Expression in Placenta of Pregnancy Induced Hypertension Complicated by Intrauterine Growth Retardation

Differential Expression of Placental 11Β-Hsd2 Induced by High Maternal Glucocorticoid Exposure Mediates Sex Differences in Placental and Fetal Development.

Involvement of STAT3 in the Synergistic Induction of 11β‐hsd1 by SAA1 and Cortisol in Human Amnion Fibroblasts

Maternal Blood Pressure, Cord Glucocorticoids, and Child Neurodevelopment at 2 Years of Age: A Birth Cohort Study.

Serial Diurnal Salivary Cortisol Profiles in 667 pregnant women – Association with Cardiometabolic Complications

11 Beta-Hsd1 In Human Fetal Membranes As A Potential Therapeutic Target For Preterm Birth

Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease

Sexually Dimorphic Effects Of Maternal Nutrient Reduction On Expression Of Genes Regulating Cortisol Metabolism In Fetal Baboon Adipose And Liver Tissues

Mechanisms for Establishment of the Placental Glucocorticoid Barrier, a Guard for Life

Influence of labor on direct and indirect determinants of placental 11beta-hydroxysteroid dehydrogenase activity

The Effect of Multiple Single Nucleotide Polymorphisms in the Folic Acid Pathway Genes on Homocysteine Metabolism